New clinical study shows clear benefits of Probi’s probiotics for Metabolic Health
A new study on metabolic syndrome conducted by researchers from School of Public Health, Sun Yat-sen University in China opens a new health area for Probi. The study, published in Clinical Nutrition, demonstrated that daily intake of Probi's proprietary strain Lacticaseibacillus paracasei 8700:2 significantly reduced cardiovascular disease risk and was able to counteract bodyweight gain and increased BMI.Metabolic syndrome poses an elevated risk of developing chronic cardiovascular disease, type II diabetes, heart disease and stroke, which can significantly reduce quality and length of life.